Bicycle Therapeutics Plc ADR (NASDAQ:BCYC) currently has a daily average trading volume of 348.71K but it saw 347957 shares traded in last market. With a market cap of 512.77M USD, the company’s current market price of $7.41 came falling about -3.01 while comparing to the previous closing price of $7.64. In past 52 weeks, the stock remained buoying in the range of price level as high as $28.67 and as low as $6.10. In the recent trading on the day, stock has struck highest price mark of $7.4 while lowest mark touched by it was $7.96.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Stephens which initiated the stock as “Equal-Weight” in its note to investors issued on November 08, 2024, recommending a price target of $25 for it. B. Riley Securities issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $33 and $28.
Over the week, BCYC’s stock price is moving -15.41% down while it is -14.14% when we observe its performance for the past one month. Year-to-date it is -47.07% down and over the past year, the stock is showing a downside performance of -67.92%.
Currently, Bicycle Therapeutics Plc ADR’s total number of outstanding shares is 69.20M. Company’s return on investment (ROI) stands at -27.37% and return on equity (ROE) at -37.13%. Stock’s beta reads 1.47. Stock has a price to book (P/B) ratio of 0.69 while price to sale or P/S ratio amounts to 19.91. Its return on asset (ROA) is -28.45% on average.
